Gregory Weaver

2018 - Sevion Therapeutics

In 2018, Gregory Weaver earned a total compensation of $522.2K as Chief Financial Officer at Sevion Therapeutics, a 67% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$138,000
Salary$347,212
Other$37,009
Total$522,221

Weaver received $347.2K in salary, accounting for 66% of the total pay in 2018.

Weaver also received $138K in non-equity incentive plan and $37K in other compensation.

Rankings

In 2018, Gregory Weaver's compensation ranked 11,730th out of 14,244 executives tracked by ExecPay. In other words, Weaver earned more than 17.6% of executives.

ClassificationRankingPercentile
All
11,730
out of 14,244
18th
Division
Manufacturing
4,736
out of 5,765
18th
Major group
Chemicals And Allied Products
1,795
out of 2,128
16th
Industry group
Drugs
1,529
out of 1,817
16th
Industry
Biological Products, Except Diagnostic Substances
296
out of 339
13th
Source: SEC filing on April 5, 2019.

Weaver's colleagues

We found three more compensation records of executives who worked with Gregory Weaver at Sevion Therapeutics in 2018.

2018

Gregory Williams

Sevion Therapeutics

Chief Operating Officer

2018

David Snow

Sevion Therapeutics

Chief Business Officer

2018

Robert Ward

Sevion Therapeutics

Chief Executive Officer

News

You may also like